TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment Option Overview for Childhood Medulloblastoma
Source: Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 11, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Table 3 describes the standard treatment options for newly diagnosed and recurrent childhood medulloblastoma.
Source links and citations
| Treatment Group | Standard Treatment Options | |
|---|---|---|
| Newly diagnosed childhood medulloblastoma | Younger children with medulloblastoma | Surgery |
| Adjuvant chemotherapy | ||
| Children older than 3 years with average-risk medulloblastoma | Surgery | |
| Adjuvant radiation therapy | ||
| Adjuvant chemotherapy | ||
| Children older than 3 years with high-risk medulloblastoma | Surgery | |
| Adjuvant radiation therapy | ||
| Adjuvant chemotherapy | ||
| Recurrent childhood medulloblastoma | There are no standard treatment options. For more information, see the Treatment of Recurrent Childhood Medulloblastoma and Other CNS Embryonal Tumors section. | |
Continue within this section
Preserved source evidence · Not medical advice